Sunshine Overseas: Transparency Rules For Life Sciences
These new requirements vary in scope, rigor and reporting deadlines — creating a patchwork of international requirements — and present significant compliance challenges for life sciences companies that conduct ex-U.S. activities such as clinical trials and international advisory boards, among others.
For instance, in December 2011, France...
Already a subscriber? Click here to login